Eli Lilly Corp. buy Royal Bank of Canada
Start price
07.05.26
/
50%
€832.20
Target price
07.05.27
-
Performance (%)
19.45%
Price
10:58
€994.10
Summary
This prediction is currently active. The prediction currently has a performance of 19.45%. This prediction currently runs until 07.05.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | 8.259% | 8.259% |
| iShares Core DAX® | -2.486% | 0.323% |
| iShares Nasdaq 100 | -4.401% | 1.587% |
| iShares Nikkei 225® | -4.295% | 0.970% |
| iShares S&P 500 | -2.199% | 2.005% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (LLY) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
Ratings data for LLY provided by MarketBeat